Skip Nav Destination
1-7 of 7
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels
K Inoue, H Ogawa, T Yamagami, T Soma, Y Tani, T Tatekawa, Y Oji, H Tamaki, T Kyo, H Dohy, A Hiraoka, T Masaoka, T Kishimoto, H Sugiyama
Blood (1996) 88 (6): 2267–2278.
WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
Blood (1994) 84 (9): 3071–3079.
Blood (1994) 84 (8): 2672–2680.
A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study Group [see comments]
R Ohno, T Naoe, A Kanamaru, M Yoshida, A Hiraoka, T Kobayashi, T Ueda, S Minami, Y Morishima, Y Saito
Blood (1994) 83 (8): 2086–2092.
No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study Group [letter]
R Ohno, A Hiraoka, M Tanimoto, N Asou, K Kuriyama, T Kobayashi, M Yoshida, H Teshima, H Saito, K Fujimoto
Blood (1993) 81 (2): 561–562.
Macrophage differentiation of human precursor B-cell line by phorbol ester and colony-stimulating factor
Blood (1982) 59 (5): 997–1000.
Relationship between in vitro colony-forming ability and expression of Ia-like antigen of acute nonlymphocytic leukemia (ANLL) cells
Blood (1980) 56 (5): 859–865.